Skip to main content
Skip to navigation
Vaccine and Infectious Disease Organization
Menu
Search the USask
Search
About
About
History
Mission, Vision, Values
Safety & Security
Facilities
Community Liaison Committee
Frequently Asked Questions
Contact Us
Annual Reports
Donor Information
Team
Board of Directors
Senior Leadership
Science Management
Principal Scientists and Veterinarians
Contract Research
Scientific Advisory Board
Access Committee
Research
Research Projects
Veterinary Services
Publications
Patents
One Health
Contract Services
All Contract Services
Contract Development and Manufacturing
Contract Research
Careers
Current Opportunities
Working at VIDO
Benefits at VIDO
Training
Visiting Scientists
News
Donate Now
Index
News Archive - 2023
VIDO’s first Animal Health Summit brings animal health stakeholders together to prepare for foot and mouth disease
VIDO scientists strengthen mpox preparedness
VIDO scientists receive leadership awards for excellence in vaccine research
VIDO receives significant CIHR support for research into emerging coronaviruses
VIDO partners with four research hubs to strengthen Canada’s infectious disease preparedness
VIDO led technology a key part of the vaccine protecting koalas from chlamydia
VIDO first non-U.S. organization invited to join high containment network
VIDO awarded U.S. contract for its Vaccine Development Centre
VIDO awarded over a million dollars for innovative research projects
VIDO and VFI collaborate to strengthen pandemic preparedness
VIDO and Pirbright expand collaboration to advance vaccine manufacturing
USask’s VIDO selected for CEPI’s international research network
The avian influenza outbreak: what you need to know
Integrating field and laboratory studies to better predict the next emerging zoonotic pathogen
CIHR supports research targeting high impact infectious diseases